Modulation of infant fat mass
View Patent ↗A method of reducing the accumulation of fat mass in a neonatal human infant at risk thereof which method comprises administering to the infant during at least a part of the neonatal period a therapeutic amount of a nutritional composition comprising proteins in an amount such that the composition contains more than 2.4 g of protein per 100 kcal. As weight gain during the first week of life has been associated with overweight in adulthood, this may offer a method of reducing the risk of developing obesity in later life. Also claimed is the administration of DHA to the mother during gestation period.
1. A method for reducing the accumulation of fat mass in a human infant during at least a part of the neonatal period comprising administering a first nutritional composition comprising between 2.4 and 3.0 g of protein per 100 kcal, followed by administration of a second nutritional composition having a protein content between 1.7 and 2.0 g protein per 100 kcal for the remainder of the first four months of the life of the infant.
2. The method of claim 1 , wherein the first nutritional composition comprises between 2.4 and 2.8 g of protein per 100 kcal.
3. The method of claim 1 , wherein the first nutritional composition is administered to the infant for the whole of the neonatal period.
4. The method of claim 1 , wherein the proteins in the first nutritional composition are intact.
5. The method of claim 1 , wherein the proteins in the first nutritional composition are partially hydrolysed.
6. The method of claim 5 wherein the degree of hydrolysis of the proteins in the first nutritional composition is between 2 and 20%.
7. The method of claim 1 , wherein the first nutritional composition is an infant formula.
8. The method of claim 1 , wherein DHA (docosahexaenoic acid) is administered to the infant as part of the first nutritional composition.
9. The method of claim 1 , wherein DHA (docosahexaenoic acid) is administered to a mother of the infant during the gestation period of the infant.
10. A method for reducing the risk of development of obesity later in life in an infant comprising administering to the infant during at least a part of the neonatal period a first nutritional composition comprising between 2.4 and 3.0 g of protein per 100 kcal, followed by administration of a second nutritional composition having a protein content between 1.7 and 2.0 g protein per 100 kcal for the remainder of the first four months of the life of the infant.
11. The method of claim 10 , wherein the first nutritional composition comprises between 2.4 and 2.8 g of protein per 100 kcal.
12. The method of claim 10 , wherein the first nutritional composition is administered to the infant for the whole of the neonatal period.
13. The method of claim 10 , wherein the proteins in the first nutritional composition are intact.
14. The method of claim 10 , wherein the proteins in the first nutritional composition are partially hydrolysed.
15. The method of claim 14 , wherein the degree of hydrolysis of the proteins in the first nutritional composition is between 2 and 20%.
16. The method of claim 10 , wherein the first nutritional composition is an infant formula.
17. The method of claim 10 , wherein DHA (docosahexaenoic acid) is administered to the infant as part of the first nutritional composition.
18. The method of claim 10 , wherein DHA (docosahexaenoic acid) is administered to a mother of the infant during the gestation period of the infant.
19. A method for obtaining a low fat body mass accumulation in an infant during the neonatal period comprising the steps of administering during at least a portion of the neonatal period a first nutritional composition comprising between 2.4 and 3.0 g of protein per 100 kcal, followed by administration of a second nutritional composition having a protein content between 1.7 and 2.0 g protein per 100 kcal for the remainder of the first four months of the life of the infant.